hims compounded glp 1 & Hers stock drops 30% after Novo Nordisk terminates deal Hims & Hers: The Risks

Data from the surpass trial series revealed that tirzepatide reduces the risk of major adverse cardiovascular events and improves blood pressure, lipid profiles, and inflammatory markers (60, 61)

Furthermore, despite the 5 % weight loss at week nine, subjects taking inulin ate significantly less (~270 kcal less, p = 0.027) at the follow-up ad libitum meal, with no consequent rebound in food intake at the 18 week visit despite a total 7 % weight loss in the inulin group, suggesting that inulins effect on weight management is mediated via appetite modulation

2010;92(3):574-584 Jarlenski MP, Bennett WL, Bleich SN, Barry CL, Stuart EA

Employers have similarly been squeezed by the cost of GLP-1 drugs